Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

Leuk Lymphoma. 2018 Jul;59(7):1756-1758. doi: 10.1080/10428194.2017.1393667. Epub 2017 Oct 31.

Emmanuelle Le Ray^{1

2}, Lisa Belin³, Corine Plancher³, Philippe Anract^{2

4}, Antoine Babinet^{2

4}, Valérie Dumaine^{2

4}, Jérôme Tamburini^{1

2

5}, Bénédicte Deau Fischer^{1

2}, Lise Willems^{1

2}, Leonardo Magro⁶, Thierry Facon⁶, Xavier Leleu⁷, Didier Bouscary^{1

2

5}, Youlia M Kirova⁸

¹ a Service d'Hématologie , Hôpital Cochin, AP-HP , Paris , France.
² b Faculté de Médecine Sorbonne Paris Cité , Université Paris Descartes , Paris , France.
³ c Department of Biostatistics , Institut Curie , Paris , France.
⁴ d Service de chirurgie orthopédique , Hôpital Cochin, AP-HP , Paris , France.
⁵ e Institut Cochin, Département Développement Reproduction Cancer , CNRS UMR8104, INSERM U1016 , Paris , France.
⁶ f Service d'Hématologie , CHRU Lille , Lille , France.
⁷ g Service d'hématologie , CHU de Poitiers , Poitiers , France.
⁸ h Department of Radiation Therapy , Institut Curie , Paris , France.

No abstract available

Publication types